<DOC>
	<DOC>NCT03102138</DOC>
	<brief_summary>This is a safety follow-up study. Patients enrolled in B4711001 will be followed for a further 4 years with regular visits to assess safety.</brief_summary>
	<brief_title>Retinal Pigment Epithelium Safety Study For Patients In B4711001</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. Previous participation in Protocol B4711001 and received treatment with PF05206388. Subjects who are willing and able to comply with scheduled visits, and study procedures. there are no exclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>